Provider review
Ivologist review
Sells an eleven-week block, which is neither two months nor three.
Its two programs use different periods, so they cannot even be compared to each other.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Ivologist
$497 for 11 weeks sema · $797 for 12 weeks tirz
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The denominators are the story. This seller quotes one program over eleven weeks and another over twelve, and neither of those is a month, a quarter, or any period you could compare against the monthly rates that make up most of this market. Eleven weeks in particular corresponds to nothing — it is not two months, not three, and not half of anything useful — so converting it to a monthly figure requires a division the seller has not performed and this page will not perform on their behalf. That the two programs use different periods compounds it: you cannot even set the semaglutide offer against the tirzepatide one without normalizing both first. Each block also shows a smaller figure alongside it, struck through from a higher one, and neither of those carries a period either, so it is unclear whether they represent a first payment, an installment, or a comparison. What is clear enough is the framing: both are described as starter programs, which implies a subsequent phase, and nothing on the page prices that phase. If you intend to hold a low dose for a long time, a starter block with an odd length and an unpriced continuation is close to the least plannable structure in this category.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the whole block total printed rather than only a divided figure
- You want a defined starter period rather than an open-ended subscription
- You are buying once to try it and not planning a year around the price
Look elsewhere if
- You are comparing monthly rates. Eleven weeks converts to nothing useful
- You want to weigh the two molecules against each other. They use different periods
- You intend to continue past the starter block. That phase is not priced
What it actually costs
Price as published
No monthly rate is published, and the supply periods map to no calendar unit: the Sema Starter Program is shown at $149 struck through from $199 with "($497 for 11 weeks)" beside it, and the Tirz Starter Program at $249 struck through from $299 with "($797 for 12 weeks)" · eleven weeks is neither two months nor three, and twelve weeks is not three months either — a quarter is thirteen — so neither block can be divided into a monthly figure that means anything, and the two programs are not even measured against each other on the same period · both headline figures are struck through from higher ones, and neither the struck nor the current figure carries a period of its own · the current and struck figures were separated by reading the price elements rather than their order · both molecules are named and both programs are described as starter programs, which implies something after them that is not priced here · no dose is published
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The supply periods map to no calendar unit — one program runs ELEVEN weeks and the other twelve, and eleven is neither two months nor three while twelve is not a quarter either. Converting them to a monthly figure requires a division the seller has not performed. The two programs use DIFFERENT periods, so they cannot even be set against each other without normalizing first. Both headline figures are struck through from higher ones and neither carries a period of its own. Both are described as starter programs, implying a subsequent phase that is not priced anywhere. No dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Both molecules are offered with their own separately priced program.
- The block total is printed rather than only a divided per-period figure.
- The programs are described as starter tracks rather than presented as open-ended.
Pharmacy, labs and oversight
Ivologist does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Ivologist publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The denominators are the story. This seller quotes one program over eleven weeks and another over twelve, and neither of those is a month, a quarter, or any period a reader could compare against the monthly rates that make up most of this market. Eleven weeks in particular corresponds to nothing — it is not two months, not three, and not half of anything useful — so converting it to a monthly figure requires a division the seller has not performed and this page will not perform on their behalf. That the two programs use different periods compounds it: a reader cannot even set the semaglutide offer against the tirzepatide one without normalizing both first. Each block also shows a smaller figure alongside it, struck through from a higher one, and neither of those carries a period either, so it is unclear whether they represent a first payment, an installment, or a comparison. What is clear enough is the framing: both are described as starter programs, which implies a subsequent phase, and nothing on the page prices that phase. For a reader who intends to hold a low dose for a long time, a starter block with an odd length and an unpriced continuation is close to the least plannable structure in this category.
The honest cons
The supply periods are eleven and twelve weeks, matching no calendar unit.
- The two programs use different periods, so they cannot be compared to each other.
- What follows the starter block is not priced anywhere, and no dose is published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Ivologist is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#274 of 373
Ordered with the companies that pay us first, and Ivologist is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.